Clinical Trials · NCT01899430
Polycystic Ovary Syndrome and Liraglutide
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- University Medical Centre Ljubljana
- Enrollment
- 32
- Start date
- Nov 2011
- Locations
- 1 site, Slovenia
- Primary endpoint
- The main outcome was change in body weight.